SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-064747
Filing Date
2023-08-09
Accepted
2023-08-09 06:48:12
Documents
14
Period of Report
2023-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183148-8k_biomxinc.htm   iXBRL 8-K 30070
2 PRESS RELEASE DATED AUGUST 9, 2023 ea183148ex99-1_biomxinc.htm EX-99.1 92812
  Complete submission text file 0001213900-23-064747.txt   356016

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE phge-20230809.xsd EX-101.SCH 3919
4 XBRL DEFINITION FILE phge-20230809_def.xml EX-101.DEF 26852
5 XBRL LABEL FILE phge-20230809_lab.xml EX-101.LAB 37192
6 XBRL PRESENTATION FILE phge-20230809_pre.xml EX-101.PRE 25476
8 EXTRACTED XBRL INSTANCE DOCUMENT ea183148-8k_biomxinc_htm.xml XML 5773
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 231153289
SIC: 2836 Biological Products, (No Diagnostic Substances)